Analytical Data
-
Gene name
CD68
- Application
-
Alternative Names
CD68; GP110; Macrosialin; Macrophage Antigen CD68
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P31996
-
Expression Region
Ala27~Pro282
-
Molecular Weight
59kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD68 is a glycoprotein predominantly expressed in the membranes of macrophages and other myeloid cells, serving as a vital marker for monocyte and macrophage differentiation. It is involved in various immune responses, including phagocytosis, antigen presentation, and modulation of inflammatory processes. Due to its role in immune system function, CD68 has garnered significant interest in research related to various diseases, including cancer, atherosclerosis, and autoimmune disorders. The study of recombinant CD68 proteins is pivotal for understanding its biological functions and mechanisms, as well as for developing potential therapeutic applications. By producing and characterizing CD68 recombinant proteins, researchers can investigate interactions with ligands, receptor signaling pathways, and the protein’s role in macrophage activation. These studies can lead to novel insights into the immune response and identify new targets for therapeutic intervention in diseases characterized by dysregulated macrophage activity. Overall, the exploration of CD68 recombinant proteins represents a crucial area of research in immunology, providing a foundation for advancements in both basic science and clinical applications.
